Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022 – PR Newswire

Added 18,985 New Subscribers in 3Q22Revenues Up 9.1% YoY to RMB317.2 Million ($49.8 Million) Gross Profit Up 9.8% YoY to RMB269.9 Million ($42.4 Million)Operating Income Up 20.8% YoY to RMB149.7 Million ($23.5 Million) Non-GAAP Operating Income Up 18.6% YoY to RMB161.6 Million ($25.4 Million)Conference Call to be Held on March 1, 2022, at 8:00 a.m. ET

HONG KONG, Feb. 28, 2022 /PRNewswire/ --Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the third quarter and first nine months of fiscal 2022, ended December 31, 2021.

Third Quarter Fiscal 2022 Highlights

First Nine Months Fiscal 2022 Highlights

"Despite ongoing challenges from a resurgence of COVID-19 and the general trend of fewer newborns in China, we managed to recruit 18,985 new subscribers in the third quarter," said Ms. Ting Zheng, Chief Executive Officer and Chairperson of GCBC. "As regulatory uncertainties affecting China's cord blood banking industry remain as we head to the Year of Tiger, management will continue to monitor any potential regulatory changes, while carrying on with our operating efforts and thoroughly examining business development opportunities related to cord blood stem cells, as we aim to generate growth in new areas."

Summary Third Quarter and Nine Months Ended December 31, 2020 and 2021

Three Months Ended December 31,

Nine Months Ended December 31,

2020

2021

2020

2021

(in thousands)

RMB

RMB

US$

RMB

RMB

US$

Revenues

290,798

317,202

49,776

857,318

946,046

148,455

Gross Profit

245,920

269,921

42,357

724,279

804,715

126,277

Operating Income[3]

123,957

149,719

23,494

396,627

466,727

73,239

Change in Fair Value of

Equity Securities

6,003

599

94

30,107

(6,416)

(1,007)

Net Income Attributable to the Company's Shareholders

116,570

134,192

21,058

380,513

396,349

62,195

Earnings per Ordinary

Share (RMB/US$)

Basic

0.96

1.11

0.17

3.13

3.26

0.51

Diluted

0.96

1.11

0.17

3.13

3.26

0.51

Revenues Breakdown (%)

Processing Fees and Other

Services

56.8%

57.1%

57.3%

57.7%

Storage Fees

43.2%

42.9%

42.7%

42.3%

New Subscribers (persons)

17,802

18,985

52,678

57,724

Total Accumulated Subscribers(persons)

882,982

955,864[1]

882,982

955,864[1]

Summary Selected Cash Flow Statement Items

Three Months Ended December 31,

Nine Months Ended December 31,

2020

2021

2020

2021

Read more:

Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022 - PR Newswire